Muhammed Amir Essibayi
Muhammed Amir Essibayi is an expert in Neurosurgery at Montefiore Medical Center (United States). As of October 2026, ScienceLeadR ranks Muhammed Amir Essibayi in the top 1% of experts worldwide for Aneurysm and Cerebrovascular Disorders. Muhammed Amir Essibayi has authored 229 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 917 (community average: 125). How the SLR is computed.
LeadR Profile
Neurosurgery
Subspecialties: Neurology - Medical Imaging - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2019 - 2026
Number : 229
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Machine Learning Prediction of Treatment Failure After Middle Meningeal Artery Embolization for Subdural Hematoma. PMID 42925034 — hematoma, treatment failure, hematoma, subdural, arteries, machine learning, therapeutics, learning, blood platelets, meningeal arteries | Neurosurgery | 2026 | 0 |
| Sex composition and FDG-PET prediction of Alzheimer's disease conversion: response to Rudroff. PMID 42800281 — alzheimer disease, aging, sex | J Nutr Health Aging | 2026 | 0 |
| Multi-pedicle versus single-pedicle middle meningeal artery embolization for nonacute subdural hematoma. PMID 42766032 — hematoma, multiple chronic conditions, hematoma, subdural, radiography, arteries, therapeutics, meningeal arteries, hemostasis | Neuroradiology | 2026 | 0 |
| Smaller WEB devices show lower retreatment rates than larger devices: results from the WorldWideWEB study. PMID 42711440 — safety, aneurysm, radiography, retreatment, therapeutics, intracranial aneurysm | Eur Radiol | 2026 | 0 |
| Effects of Glucagon-Like Peptide-1 Receptor Agonist Use After Transient Ischemic Attack on Risks of Subsequent Ischemic Stroke and Mortality. PMID 42683794 — glucagon-like peptide 1, mortality, glucagon-like peptide-1 receptor, ischemic stroke, stroke, ischemic attack, transient, diagnosis, glucagon, glucagon-like peptides | J Clin Neurol | 2026 | 1 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| International Registry of Intra arterial and Endosaccular Flow Diverters (IRF) NCT06174727 — registries, stents, aneurysm, therapeutics, intracranial aneurysm | N/A | Recruiting | 2023 |
| Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH) NCT06181994 — hematoma, hematoma, subdural, chronic, hematoma, subdural, arteries, therapeutics, meningeal arteries | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map